A method for chemical production includes applying electromagnetic heating to a composition that includes a catalytic component and an electromagnetic susceptor. Responsive to application of radio frequency energy, the electromagnetic susceptor causes the catalytic component to become heated. The heated electromagnetic susceptor and catalytic component interact with a chemical to form a product.

Modular reactors comprising a chassis, reactor tubing and optionally a cover are disclosed. The chassis comprises a plurality of channels of different lengths into which a length of reactor tubing is placed to create the reactor portion of the flow reactor.

Modular reactors comprising a chassis, reactor tubing and optionally a cover are disclosed. The chassis comprises a plurality of channels of different lengths into which a length of reactor tubing is placed to create the reactor portion of the flow reactor.

A microfluidic device includes a channel through which a reaction solution flows. The channel passes through a reaction section having a plurality of temperature zones set at predetermined different temperatures. The channel includes, at least in the reaction section, a region where a cross-sectional area decreases in a feeding direction of the reaction solution.

Fluid transport approaches are described that operate without the need for precise displacement of an actuator and with little or no sensing in the flow path. In certain implementations, a gas phase in a fluid reservoir is compressed by a pressure source such that releasing the pressure, such as by opening a valve to an intermediary conduit, displaces fluid to the intermediary chamber. Closing that fluid path and opening a different fluid path to a chamber at ambient temperature causes the fluid to be displaced to the chamber.

The present invention relates to a continuous micro-electro-flow reactor system for ultra-fast, oxidant free, C—C coupling reaction for making symmetrical biaryls and analogs thereof. This invention further relates to the said process for preparation of antiviral drug, daclatasvir of general formula I.

The invention discloses a reactor for preparing a formulation. The reactor comprises at least two apertures, a base and at least one sidewall extending flush therefrom, wherein the base and the sidewall together define a mixing chamber with a height h.sub.M and at least one axis of symmetry arranged substantially perpendicular to the base and at least one distance r from the sidewall. A first aperture is arranged within the base or adjacent to the base in the sidewall of the mixing chamber at a height h.sub.A ranging from 0.6 to 0.0 h.sub.M in order to introduce free-flowing materials and/or mixtures to the mixing chamber. The first aperture is configured with a non-return valve disposed therein or adjacent thereto, the non-return valve permitting the introduction of free-flowing materials to the mixing chamber through the aperture, but preventing outflow of free-flowing materials from the mixing chamber through the aperture. The first aperture is formed with an aperture area extending in a range between a minimum and a maximum, the minimum area being 0.05 mm.sup.2 and the maximum area being determined by a value resulting from Volume.sub.mixing chamber [cm.sup.3]/Area.sub.first aperture [cm.sup.2]≈5500.

The invention is in the field of catalysis. In particular, the invention is directed to a catalytic reactor body, a method for the production of a catalytic reactor body and a use of a catalytic reactor body.

The invention provides a catalytic reactor body, comprising a circumferential reactor wall extending in a main fluid flow direction of the reactor body between a reactor inlet and a reactor outlet thereby forming a channel for conducting a fluid; and a reactor bed arranged in the channel and being integrally formed with the circumferential reactor wall, wherein the reactor bed forms a plurality of sub-channels for guiding the fluid from the reactor inlet to the reactor outlet, each sub-channel defining a predetermined fluid path between the reactor inlet and the reactor outlet and being configured for directing the fluid in a direction at least partly transverse to the main flow direction.

The present disclosure is directed towards improved systems and methods for large-scale production of nanoparticles used for delivery of therapeutic material. The apparatus can be used to manufacture a wide array of nanoparticles containing therapeutic material including, but not limited to, lipid nanoparticles and polymer nanoparticles. In certain embodiments, continuous flow operation and parallelization of microfluidic mixers contribute to increased nanoparticle production volume.

The invention discloses a reactor for preparing a formulation. The reactor comprises at least two apertures, a base and at least one sidewall extending flush therefrom, wherein the base and the sidewall together define a mixing chamber with a height h.sub.M and at least one axis of symmetry arranged substantially perpendicular to the base and at least one distance r from the sidewall. A first aperture is arranged within the base or adjacent to the base in the sidewall of the mixing chamber at a height h.sub.A ranging from 0.6 to 0.0 h.sub.M in order to introduce free-flowing materials and/or mixtures to the mixing chamber. The first aperture is configured with a non-return valve disposed therein or adjacent thereto, the non-return valve permitting the introduction of free-flowing materials to the mixing chamber through the aperture, but preventing outflow of free-flowing materials from the mixing chamber through the aperture. The first aperture is formed with an aperture area extending in a range between a minimum and a maximum, the minimum area being 0.05 mm.sup.2 and the maximum area being determined by a value resulting from Volume.sub.mixing chamber [cm.sup.3]/Area.sub.first aperture [cm.sup.2]≈5500.